Cargando…

The Impact of Brexit on Pharmaceuticals and HTA

Detalles Bibliográficos
Autor principal:	Lorgelly, Paula K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2018
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972122/ https://www.ncbi.nlm.nih.gov/pubmed/29557537 http://dx.doi.org/10.1007/s41669-018-0072-5

Ejemplares similares

Evaluating the impact of Brexit on the pharmaceutical industry
por: Kazzazi, Fawz, et al.
Publicado: (2017)

Expanding HTA – Correcting a Misattribution, Clarifying the Scope of HTA and CEA: Comment on "Ethics in HTA: Examining the ‘Need for Expansion’"
por: Culyer, Anthony J.
Publicado: (2019)

The Impact of Brexit on the Pharmaceutical Supply Chain of the United Kingdom: Scoping Review Protocol
por: Milne-Ives, Madison, et al.
Publicado: (2020)

Impact of a Global Pandemic on Health Technology Assessment
por: Lorgelly, Paula K., et al.
Publicado: (2020)

Trump, Brexit, Right-wing Anti-globalisation, and An Uncertain Future for Public Health
por: Macgregor-Bowles, Isabelle, et al.
Publicado: (2017)

Equity in HTA: what doesn’t get measured, gets marginalised
por: Cookson, Richard, et al.
Publicado: (2017)

The impact of Brexit on oral health
por: Coughlan, James, et al.
Publicado: (2020)

Regulatory policy and pharmaceutical innovation in the United Kingdom after Brexit: Initial insights
por: Hofer, Matthias P., et al.
Publicado: (2022)

Brexit For Dummies
por: Wallwork, Nicholas
Publicado: (2019)

Evidence-Informed Deliberative Processes for HTA Around the Globe: Exploring the Next Frontiers of HTA and Best Practices Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
por: Gopinathan, Unni, et al.
Publicado: (2020)

Health Reform in Aotearoa New Zealand: Insights on Health Equity Challenges One Year On
por: Lorgelly, Paula K., et al.
Publicado: (2023)

The Brexit impact on European market co-movements
por: Ben Ameur, Hachmi, et al.
Publicado: (2021)

Brexit and Animal Welfare Impact Assessment: Analysis of the Threats Brexit Poses to Animal Protection in the UK, EU and Internationally
por: McCulloch, Steven P.
Publicado: (2019)

Brexit and Animal Welfare Impact Assessment: Analysis of the Opportunities Brexit Presents for Animal Protection in the UK, EU, and Internationally
por: McCulloch, Steven P.
Publicado: (2019)

Brexit and Translational Research
Publicado: (2016)

The Radicalization of Brexit Activists
por: Mason, Clare B., et al.
Publicado: (2022)

PNS173 Impact of COVID-19 on HTA Bodies and Pharmaceutical Company Pricing and Market Access Activities
por: Thomas, M., et al.
Publicado: (2020)

Fair Processes for Priority Setting: Putting Theory into Practice : Comment on "Expanded HTA: Enhancing Fairness and Legitimacy"
por: Jansen, Maarten P., et al.
Publicado: (2016)

Impact of COVID-19 pandemic on HTA
Publicado: (2020)

HTA and National Immunisation Program: an overview of competent bodies and of the impact of HTA on the decision-making process
por: Ricciardi, W
Publicado: (2022)

Pharmaceutical companies’ views on a health technology assessment (HTA) entity in Saudi Arabia
por: Al-Omar, Hussain Abdulrahman, et al.
Publicado: (2020)

The Need for Global Application of the Accountability for Reasonableness Approach to Support Sustainable Outcomes: Comment on "Expanded HTA: Enhancing Fairness and Legitimacy"
por: Byskov, Jens, et al.
Publicado: (2016)

STEM CAREERS IN THE BREXIT ERA
Publicado: (2020)

Brexit’s Implications for the Transatlantic Relationship
por: Prikhodko, O. V.
Publicado: (2022)

Reflections: the UK after Brexit
por: Oliver, Tim
Publicado: (2023)

HTA253 Payer Perspectives on the Impact of the COVID-19 Pandemic on Health Technology Assessments (HTA) in Europe
por: Hutcheson, R, et al.
Publicado: (2022)

Navigating HTA implementation: a review of Indonesia’s revised HTA guideline
por: Chavarina, Kinanti Khansa, et al.
Publicado: (2023)

Strengthening international patient advocacy perspectives on patient involvement in HTA within the HTAi Patient and Citizen Involvement Interest Group – Commentary
por: Wale, Janet L., et al.
Publicado: (2017)

Brexit and the NHS: voting behaviour and views on the impact of leaving the EU
por: Drinkwater, Stephen, et al.
Publicado: (2022)

GMS-HTA: Information out of the world of HTA - up-to-date, comprehensive and valid
por: Rüther, Alric
Publicado: (2005)

Brexit and What It Means for Global Health
por: Greenwood, Brian
Publicado: (2018)

Wind of Change: Brexit and European Rehabilitation
por: Villafañe, Jorge Hugo, et al.
Publicado: (2017)

Mapping post-Brexit environmental law
por: Reid, Colin T.
Publicado: (2020)

The implications of Brexit for the Irish health system
por: Turner, Brian
Publicado: (2020)

Brexit y profesionales sanitarios comunitarios
por: Galí Gorina, Ferran
Publicado: (2017)

Performance, Politics and Boris Johnson's Brexit
por: Senior, Carl, et al.
Publicado: (2021)

EU‐27 Public Opinion on Brexit
por: Walter, Stefanie
Publicado: (2020)

Science in a post-Brexit gridlock
Publicado: (2022)

Value Insider Season 1 Episode 1: The Importance of Payers and HTA: How Did We End Up Here? (Introduction to Value) [Podcast]
por: Drummond, Michael F, et al.
Publicado: (2022)

The Association for Human Pharmacology in the Pharmaceutical Industry London Meeting 2018: Brexit and Other Challenges in Early Phase Drug Development
por: Reijntjes, Susan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l3oflaljoq2thpt70aq2emlb5g